Novel Approaches in Primary Cardiovascular Disease Prevention: The HOPE-3 Trial Rationale, Design, and Participants' Baseline Characteristics

Background: Cholesterol and blood pressure (BP) can be effectively and safely lowered with statin drugs and BP-lowering drugs, reducing major cardiovascular (CV) events by 20%-30% within 5 years in high-risk individuals. However, there are limited data in lower-risk populations. The Heart Outcomes P...

詳細記述

書誌詳細
出版年:	Canadian Journal of Cardiology
第一著者:	Lonn E.; Bosch J.; Pogue J.; Avezum A.; Chazova I.; Dans A.; Diaz R.; Fodor G.J.; Held C.; Jansky P.; Keltai M.; Keltai K.; Kunti K.; Kim J.-H.; Leiter L.; Lewis B.; Liu L.; Lopez-Jaramillo P.; Pais P.; Parkhomenko A.; Peters R.J.G.; Piegas L.S.; Reid C.M.; Sliwa K.; Toff W.D.; Varigos J.; Xavier D.; Yusoff K.; Zhu J.; Dagenais G.; Yusuf S.
フォーマット:	論文
言語:	English
出版事項:	Elsevier Inc. 2016
オンライン･アクセス:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-84959279879&doi=10.1016%2fj.cjca.2015.07.001&partnerID=40&md5=f6832d88b7627fbe40a5bb45ad1c94c6

インターネット

https://www.scopus.com/inward/record.uri?eid=2-s2.0-84959279879&doi=10.1016%2fj.cjca.2015.07.001&partnerID=40&md5=f6832d88b7627fbe40a5bb45ad1c94c6

類似資料

Rationale, Design and Baseline Characteristics of Participants in the Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS) Trial
著者:: Bosch J.; Eikelboom J.W.; Connolly S.J.; Bruns N.C.; Lanius V.; Yuan F.; Misselwitz F.; Chen E.; Diaz R.; Alings M.; Lonn E.M.; Widimsky P.; Hori M.; Avezum A.; Piegas L.S.; Bhatt D.L.; Branch K.R.H.; Probstfield J.L.; Liang Y.; Liu L.; Zhu J.; Maggioni A.P.; Lopez-Jaramillo P.; O'Donnell M.; Fox K.A.A.; Kakkar A.; Parkhomenko A.N.; Ertl G.; Störk S.; Keltai K.; Keltai M.; Ryden L.; Dagenais G.R.; Pogosova N.; Dans A.L.; Lanas F.; Commerford P.J.; Torp-Pedersen C.; Guzik T.J.; Verhamme P.B.; Vinereanu D.; Kim J.-H.; Ha J.-W.; Tonkin A.M.; Varigos J.D.; Lewis B.S.; Felix C.; Yusoff K.; Steg P.G.; Aboyans V.; Metsarinne K.P.; Anand S.S.; Hart R.G.; Lamy A.; Moayyedi P.; Leong D.P.; Sharma M.; Yusuf S.
出版事項: (2017)
Urinary sex steroids and anthropometric markers of puberty - A novel approach to characterising within-person changes of puberty hormones
著者:: Singh G.K.S.; Balzer B.W.R.; Kelly P.J.; Paxton K.; Hawke C.I.; Handelsman D.J.; Steinbeck K.S.
出版事項: (2015)
Local structural analysis of erbium-doped tellurite modified silica glass with x-ray photoelectron spectroscopy
著者:: Ahmad Kamil S.; Chandrappan J.; Portoles J.; Steenson P.; Jose G.
出版事項: (2019)
Variations in knowledge, awareness and treatment of hypertension and stroke risk by country income level
著者:: O'Donnell M.; Hankey G.J.; Rangarajan S.; Chin S.L.; Rao-Melacini P.; Ferguson J.; Xavier D.; Lisheng L.; Zhang H.; Pais P.; Lopez-Jaramillo P.; Damasceno A.; Langhorne P.; Rosengren A.; Dans A.L.; Elsayed A.; Avezum A.; Mondo C.; Smyth A.; Judge C.; Diener H.-C.; Ryglewicz D.; Czlonkowska A.; Pogosova N.; Weimar C.; Iqbal R.; Diaz R.; Yusoff K.; Yusufali A.; Oguz A.; Wang X.; Penaherrera E.; Lanas F.; Ogah O.S.; Ogunniyi A.; Iversen H.K.; Malaga G.; Rumboldt Z.; Oveisgharan S.; Alhussain F.; Daliwonga M.; Nilanont Y.; Yusuf S.
出版事項: (2021)
Systemic VEGF-A neutralization ameliorates diet-induced metabolic dysfunction
著者:: Wu L.E.; Meoli C.C.; Mangiafico S.P.; Fazakerley D.J.; Cogger V.C.; Mohamad M.; Pant H.; Kang M.-J.; Powter E.; Burchfield J.G.; Xirouchaki C.E.; Mikolaizak A.S.; Stöckli J.; Kolumam G.; Van Bruggen N.; Gamble J.R.; Le Couteur D.G.; Cooney G.J.; Andrikopoulos S.; James D.E.
出版事項: (2014)